{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:24:00Z","timestamp":1746336240883},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ejim.2010.10.002","type":"journal-article","created":{"date-parts":[[2010,11,14]],"date-time":"2010-11-14T09:28:34Z","timestamp":1289726914000},"page":"77-83","source":"Crossref","is-referenced-by-count":11,"title":["Serum surrogate markers of liver fibrosis in primary biliary cirrhosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Argiro","family":"Voumvouraki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mairi","family":"Koulentaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Notas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ourania","family":"Sfakianaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Kouroumalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2010.10.002_bb0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-6-34","article-title":"Diagnostic value of biochemical markers (nashtest) for the prediction of non-alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Poynard","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0010","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1582-4934.2007.00092.x","article-title":"Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality","volume":"11","author":"Gressner","year":"2007","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ejim.2010.10.002_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-7-40","article-title":"Meta-analyses of fibrotest diagnostic value in chronic liver disease","volume":"7","author":"Poynard","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0020","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/gut.2008.154435","article-title":"Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (nafld)?","volume":"57","author":"Chavez-Tapia","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2010.10.002_bb0025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1440-1746.2009.05806.x","article-title":"Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?","volume":"24","author":"Hashimoto","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1665-2681(19)31784-3","article-title":"Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease","volume":"8","author":"Vizzutti","year":"2009","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0035","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3851\/IMP1570","article-title":"Biomarkers of liver injury for hepatitis clinical trials: A meta-analysis of longitudinal studies","volume":"15","author":"Poynard","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ejim.2010.10.002_bb0040","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: A cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2010.10.002_bb0045","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.22517","article-title":"Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay","volume":"48","author":"Mayo","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2010.10.002_bb0050","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.3748\/wjg.14.3628","article-title":"Is there a place for serum laminin determination in patients with liver disease and cancer?","volume":"14","author":"Rosa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0055","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.23046","article-title":"Adipokines in liver diseases","volume":"50","author":"Marra","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2010.10.002_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A: Pathol Anat Histol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0065","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2036.2001.00996.x","article-title":"Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a no-independent mechanism in chronic liver disease","volume":"15","author":"Matrella","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2010.10.002_bb0070","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1373\/clinchem.2007.085795","article-title":"Standardization of roc curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages","volume":"53","author":"Poynard","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejim.2010.10.002_bb0075","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1572-0241.2004.30110.x","article-title":"Evaluation of liver fibrosis: A concise review","volume":"99","author":"Afdhal","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8278(86)80075-7","article-title":"Complications following percutaneous liver biopsy: A multicentre retrospective study on 68, 276 biopsies","volume":"2","author":"Piccinino","year":"1986","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0085","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/jcp.49.7.556","article-title":"Accuracy of staging in primary biliary cirrhosis","volume":"49","author":"Garrido","year":"1996","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MCG.0b013e3181a84b8d","article-title":"Assessment of liver fibrosis and steatosis in pbc with fibroscan, mri, mr-spectroscopy, and serum markers","volume":"44","author":"Friedrich-Rust","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0095","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2893.2006.00736.x","article-title":"Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis c patients: Proposal for a pragmatic approach classification without liver biopsies","volume":"13","author":"Bourliere","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejim.2010.10.002_bb0100","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2005.10.019","article-title":"Performance of serum marker panels for liver fibrosis in chronic hepatitis C","volume":"44","author":"Parkes","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.21984","article-title":"Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver fibrosis panel and exploring simple markers","volume":"47","author":"Guha","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2010.10.002_bb0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.gastro.2008.09.013","article-title":"Performance of elf serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease","volume":"136","author":"Nobili","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2010.10.002_bb0115","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.1840190314","article-title":"Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: Role of serum markers of connective tissue","volume":"19","author":"Poupon","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2010.10.002_bb0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/hep.1840080127","article-title":"Serum hyaluronate in primary biliary cirrhosis: A biochemical marker for progressive liver damage","volume":"8","author":"Nyberg","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2010.10.002_bb0125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2796.1992.tb00964.x","article-title":"Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: Relation to clinical symptoms, liver histopathology and outcome","volume":"231","author":"Nyberg","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2010.10.002_bb0130","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1440-1746.1996.tb00024.x","article-title":"Aminoterminal propeptide of type iii procollagen and hyaluronan in patients with primary biliary cirrhosis: Markers of fibrosis in primary biliary cirrhosis","volume":"11","author":"Remmel","year":"1996","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0135","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1478-3231.2008.01722.x","article-title":"Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy","volume":"28","author":"Farkkila","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2010.10.002_bb0140","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1478-3231.2006.01312.x","article-title":"Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease","volume":"26","author":"Lydatakis","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2010.10.002_bb0145","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/clinchem\/42.4.558","article-title":"Diagnostic accuracy of hyaluronan and type iii procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis c evaluated by ROC curve analysis","volume":"42","author":"Guechot","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejim.2010.10.002_bb0150","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1440-1746.2006.04447.x","article-title":"Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease","volume":"21","author":"Kaneda","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0006-291X(88)90582-7","article-title":"Hyaluronic acid synthesis and secretion by rat liver fat storing cells (perisinusoidal lipocytes) in culture","volume":"151","author":"Gressner","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejim.2010.10.002_bb0160","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1478-3231.2006.01356.x","article-title":"Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis c virus infection","volume":"26","author":"Parise","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2010.10.002_bb0165","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2893.2008.00992.x","article-title":"Serum levels of ykl-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis c virus infection","volume":"15","author":"Schiavon","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejim.2010.10.002_bb0170","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00535-007-2014-3","article-title":"Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage","volume":"42","author":"Yoneda","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0175","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1440-1746.1992.tb01492.x","article-title":"Clinical significance of the serum levels of the 7s domain of type IV collagen in patients with primary biliary cirrhosis","volume":"7","author":"Fukutomi","year":"1992","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0180","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1572-0241.2007.01322.x","article-title":"Usefulness of a combined evaluation of the serum adiponectin level, homa-ir, and serum type IV collagen 7s level to predict the early stage of nonalcoholic steatohepatitis","volume":"102","author":"Shimada","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0185","first-page":"95","article-title":"The predictive value of serum laminin for portal hypertension in chronic liver diseases","volume":"35","author":"Gressner","year":"1988","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ejim.2010.10.002_bb0190","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1093\/clinchem\/34.10.2026","article-title":"Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases","volume":"34","author":"Kropf","year":"1988","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejim.2010.10.002_bb0195","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0009-9120(92)90150-Q","article-title":"Clinical significance of serum 7s collagen in various liver diseases","volume":"25","author":"Yamada","year":"1992","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ejim.2010.10.002_bb0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2362.1985.tb00156.x","article-title":"Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease","volume":"15","author":"Niemela","year":"1985","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2010.10.002_bb0205","first-page":"82","article-title":"Serum assays for liver fibrosis","volume":"22","author":"Schuppan","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/bj2610037","article-title":"Uptake and degradation in vivo and in vitro of laminin and nidogen by rat liver cells","volume":"261","author":"Smedsrod","year":"1989","journal-title":"Biochem J"},{"key":"10.1016\/j.ejim.2010.10.002_bb0215","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0168-8278(02)00102-2","article-title":"Leptin is essential for the hepatic fibrogenic response to chronic liver injury","volume":"37","author":"Leclercq","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0220","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/gast.2002.32995","article-title":"Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat","volume":"122","author":"Ikejima","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2010.10.002_bb0225","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhep.2006.10.002","article-title":"Leptin and liver tissue repair: Do rodent models provide the answers?","volume":"46","author":"Marra","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0230","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.34738","article-title":"Serum leptin in nash correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?","volume":"36","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2010.10.002_bb0235","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1155\/2007\/876076","article-title":"Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis c","volume":"21","author":"Myers","year":"2007","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0240","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2893.2003.00483.x","article-title":"The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis c","volume":"11","author":"Piche","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejim.2010.10.002_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-8278(00)80156-7","article-title":"Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis","volume":"33","author":"Testa","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1478-3231.2004.0918.x","article-title":"Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in udca-treated patients with primary biliary cirrhosis","volume":"24","author":"Corpechot","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2010.10.002_bb0255","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.3748\/wjg.v12.i23.3682","article-title":"Noninvasive fibrosis biomarkers reduce but not substitute the need for liver biopsy","volume":"12","author":"Sebastiani","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0260","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gut.2005.084475","article-title":"An appraisal of the histopathological assessment of liver fibrosis","volume":"55","author":"Standish","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2010.10.002_bb0265","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jhep.2007.02.017","article-title":"Non-invasive tests for liver fibrosis: Encouraging or discouraging results?","volume":"46","author":"Burroughs","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0270","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.cgh.2006.07.006","article-title":"Fibrosis as an end point for clinical trials in liver disease: A report of the international fibrosis group","volume":"4","author":"McHutchison","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0275","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2007.01.003","article-title":"Hepatology may have problems with putative surrogate outcome measures","volume":"46","author":"Gluud","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2010.10.002_bb0280","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.21151","article-title":"Assessment of biliary fibrosis by transient elastography in patients with pbc and psc","volume":"43","author":"Corpechot","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2010.10.002_bb0285","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2036.2007.03585.x","article-title":"Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis","volume":"27","author":"Gomez-Dominguez","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2010.10.002_bb0290","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, fibrotest, apri, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Castera","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2010.10.002_bb0295","doi-asserted-by":"crossref","DOI":"10.1111\/j.1478-3231.2010.02331.x","article-title":"Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy","author":"Myers","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2010.10.002_bb0300","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhep.2010.04.006","article-title":"Serum fibrosis markers. Death by validation or a leap of faith?","volume":"53","author":"Ratziu","year":"2010","journal-title":"J Hepatol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620510002098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620510002098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T06:47:32Z","timestamp":1711954052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620510002098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0953620510002098"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2010.10.002","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}